论文信息 - A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma. - 字舞流文

A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma.

E. Winer | W. Barry | H. Rugo | H. Burstein | M. Koehler | B. Overmoyer | S. Come | T. Mulvey | K. Miller | E. Mayer | R. Jeselsohn | A. Waks | A. Demichele | C. Huang Bartlett | H. Guo